Navigation Links
Accuray Successfully Completes Acquisition of TomoTherapy
Date:6/13/2011

SUNNYVALE, Calif., June 13, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it has completed its previously announced acquisition of TomoTherapy Incorporated (Nasdaq: TOMO). The combination creates the premier radiation oncology company, offering best-in-class technologies to fight cancer.  The combined company is focused on developing, manufacturing and selling personalized, leading-edge treatment solutions that revolve around the patient.

"The successful closing of this transaction is a significant accomplishment and an important milestone in Accuray's history. Scale is important in the capital equipment industry, and today Accuray's installed base more than doubles, generating greater opportunity for service revenue and for replacement business over time to customers who have purchased these best-in-class technologies," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "We appreciate the support of our investors and the contributions of our stakeholders who helped us achieve this important transaction.  We look forward to working toward achieving our goals as a stronger, unified company."

Accuray now offers radiation treatments tailored to the specific needs of each patient, ranging from high-precision radiosurgery for early-stage and localized disease to image-guided, intensity-modulated radiation therapy for more advanced disease sites throughout the body. These complementary patient populations are treated by the same medical specialty, creating a broader base of sales relationships for the company to leverage. By bringing together the expertise and complementary resources of both companies, Accuray becomes a stronger organization with greater scale to invest in the R&D that will keep it on the leading edge of innovation.

"This acquisition places Accuray in two market segments
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
2. Accuray Incorporateds CEO to Speak at Jefferies 2011 Global Healthcare Conference
3. Accuray Showcases CyberKnife Robotic Radiosurgery System at American Urological Association Meeting
4. Accuray Announces Results for Third Quarter of Fiscal 2011
5. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
6. Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011
7. Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference
8. Accuray to Acquire TomoTherapy for Approximately $277 Million in Cash and Stock
9. Accurays General Counsel Wins Best Bay Area Corporate Counsel Award
10. Accuray Announces Results for Second Quarter of Fiscal 2011
11. Accuray Hires Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Ascletis announced today the completion ... investment was led by C-Bridge Capital, joined by Tasly ... The valuation of the Company before financing was US$300 ... be used to expand Ascletis, pipeline, strengthen global development ... the support of the investors, Ascletis is now entering ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 The ... 30 marketed branded drugs and hundreds of generics. While ... share of branded therapeutics is expected to increase to ... to the development and launch of novel pipeline products ... therapeutics is the largest in terms of revenues, driven ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015  Amgen ... collaboration with Novartis in the areas of Alzheimer,s ... entry into Alzheimer,s disease by teaming up with ... disease program directed at genetically predisposed individuals at ... Amgen to focus on the commercialization of its ...
Breaking Medicine Technology:Ascletis Secures US$35 Million Financing 2Ascletis Secures US$35 Million Financing 3Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 2Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9
(Date:9/2/2015)... ... September 02, 2015 , ... Every year at this time, students prepare to ... are prepared to face the academic workload confronting them. They just don’t have the ... since schools don’t teach students how to study. , “Bankers bank. Salesmen sell. Teachers ...
(Date:9/2/2015)... ... September 02, 2015 , ... The 2015 China ... international investment and business conference will be hosted at five star Beijing Kunlun ... full-weekend networking conference will feature leading EB-5 industry professionals and Chinese private equity ...
(Date:9/2/2015)... ... September 02, 2015 , ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ... its negative impact on consumers. It was reported that 33% are paying an average ... much as an extra $100 compared to last year. Among the drugs that saw ...
(Date:9/2/2015)... ... September 02, 2015 , ... Amada Senior Care, premier provider of in-home care ... Johnson County location. Amada franchise partners Mike and Mell Fleming came to ... and spent over 20 years in medical device sales while Mell spent over 30 ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... engineer of patented products, announces Hand Free Pocket Cop, a safety invention that ... in the US is worth $31 billion," says Scott Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... that polymerase chain reaction (PCR) testing for Borrelia burgdorferi ... may confirm the diagnosis of Lyme arthritis, but is ... patients whose arthritis persists after antibiotic therapy. Findings of ... , a journal of the American College of Rheumatology ...
... DENVER According to a new study conducted by researchers ... pulmonary disease (COPD) an effective workout and one that, ... "Our study showed that COPD patients exercised at ... five minutes of specified Wii Fitexercises, indicating the Wii Fit ...
... , MONDAY, May 16 (HealthDay News) -- A chemical ... may pose a health risk, a new study indicates. ... at levels of the chemical, isocyanic acid, in the ... chemical with conventional measurement techniques, explained the U.S. National ...
... , MONDAY, May 16 (HealthDay News) -- Asthma patients ... flares can suffer worse outcomes, including hospitalization. That,s ... patients in two New York City emergency departments. They ... and their attempts at self-management before they decided to ...
... Randy Dotinga HealthDay Reporter , MONDAY, May 16 (HealthDay ... infested by parasites despite clinical evidence to the contrary. Now, ... in the patient,s head -- is often right on target. ... bugs, worms or germs had invaded their skin. In all but ...
... an explanation of how stroke patients can achieve better recovery. ... has proved to benefit recovery during the later phases of ... a hormone that is found in the blood and contributes ... of this hormone are higher in people who exercise regularly ...
Cached Medicine News:Health News:Deer tick bacteria DNA in joint fluid not reliable marker of active lyme arthritis 2Health News:Deer tick bacteria DNA in joint fluid not reliable marker of active lyme arthritis 3Health News:COPD patients may breathe easier, thanks to the Wii 2Health News:COPD patients may breathe easier, thanks to the Wii 3Health News:Chemical in Smoke May Pose Health Risk 2Health News:Don't Delay Emergency Care When Asthma Flare-Ups Strike 2Health News:For Some, Bugs Crawling on Skin Is a Delusion 2Health News:Hormone improves long-term recovery from stroke 2
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
... name from its first known site of ... of PSA circulates bound to anti-chymotrypsin (PSA-ACT) ... PSA are elevated in patients with prostate ... [1-3]. In addition, PSA serum levels appear ...
... of Vision and Contrast Sensitivity. The ... and glare luminance levels for accurate ... with/without glare and background luminance Comply ... standards. All Light Levels Microprocessor Controlled ...
Medicine Products: